China NMPA Inspection - Guangxi Pharmaceutical Technology Medical Supplies Factory - July 28, 2016

An important report was issued on July 28, 2016, concerning an unannounced inspection of Guangxi Pharmaceutical Technology Medical Supplies Factory. The inspection followed the company's submission of an "Application Report for Suspension of Production and Rectification" on May 1, 2016, to the Guangxi Zhuang Autonomous Region Food and Drug Administration and the Wuzhou Municipal Food and Drug Administration. The inspection team verified that the factory was indeed in a state of suspended production. Under the regulatory framework governed by the Guangxi Zhuang Autonomous Region Food and Drug Administration, the factory is required to take specific actions before resuming operations. Specifically, it must submit a written report to the Guangxi Zhuang Autonomous Region Food and Drug Administration, and production can only recommence after the regulatory authority conducts its own verification and confirms that all necessary requirements have been met.